These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24900280)

  • 61. The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine.
    Lin P; Chang L; Devita RJ; Young JR; Eid R; Tong X; Zheng S; Ball RG; Tsou NN; Chicchi GG; Kurtz MM; Tsao KL; Wheeldon A; Carlson EJ; Eng W; Burns HD; Hargreaves RJ; Mills SG
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5191-8. PubMed ID: 17637506
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.
    Sakauchi N; Kohara Y; Sato A; Suzaki T; Imai Y; Okabe Y; Imai S; Saikawa R; Nagabukuro H; Kuno H; Fujita H; Kamo I; Yoshida M
    J Med Chem; 2016 Apr; 59(7):2989-3002. PubMed ID: 26954848
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
    Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
    J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Diaryl substituted pyrazoles as potent CCR2 receptor antagonists.
    Pinkerton AB; Huang D; Cube RV; Hutchinson JH; Struthers M; Ayala JM; Vicario PP; Patel SR; Wisniewski T; DeMartino JA; Vernier JM
    Bioorg Med Chem Lett; 2007 Feb; 17(3):807-13. PubMed ID: 17088058
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.
    Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M
    J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor.
    Johnson DS; Stiff C; Lazerwith SE; Kesten SR; Fay LK; Morris M; Beidler D; Liimatta MB; Smith SE; Dudley DT; Sadagopan N; Bhattachar SN; Kesten SJ; Nomanbhoy TK; Cravatt BF; Ahn K
    ACS Med Chem Lett; 2011 Feb; 2(2):91-96. PubMed ID: 21666860
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists.
    Apel AK; Cheng RKY; Tautermann CS; Brauchle M; Huang CY; Pautsch A; Hennig M; Nar H; Schnapp G
    Structure; 2019 Mar; 27(3):427-438.e5. PubMed ID: 30581043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimization of a series of potent, selective and orally bioavailable SYK inhibitors.
    Grimster NP; Gingipalli L; Barlaam B; Su Q; Zheng X; Watson D; Wang H; Simpson I; Pike A; Balazs A; Boiko S; Ikeda TP; Impastato AC; Jones NH; Kawatkar S; Kemmitt P; Lamont S; Patel J; Read J; Sarkar U; Sha L; Tomlinson RC; Wang H; Wilson DM; Zehnder TE; Wang L; Wang P; Goldberg FW; Shao W; Fawell S; Dry H; Dowling JE; Edmondson SD
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127433. PubMed ID: 32717371
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Design and synthesis of novel small molecule CCR2 antagonists: evaluation of 4-aminopiperidine derivatives.
    Vilums M; Zweemer AJ; Dekkers S; Askar Y; de Vries H; Saunders J; Stamos D; Brussee J; Heitman LH; IJzerman AP
    Bioorg Med Chem Lett; 2014 Dec; 24(23):5377-80. PubMed ID: 25453791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
    Auvynet C; Baudesson de Chanville C; Hermand P; Dorgham K; Piesse C; Pouchy C; Carlier L; Poupel L; Barthélémy S; Felouzis V; Lacombe C; Sagan S; Chemtob S; Quiniou C; Salomon B; Deterre P; Sennlaub F; Combadière C
    FASEB J; 2016 Jun; 30(6):2370-81. PubMed ID: 26979087
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High-content analysis of CCR2 antagonists on human primary monocytes.
    Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
    J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6).
    Motoyama K; Nagata T; Kobayashi J; Nakamura A; Miyoshi N; Kazui M; Sakurai K; Sakakura T
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2222-2227. PubMed ID: 29752182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.
    Blackaby WP; Lewis RT; Thomson JL; Jennings AS; Goodacre SC; Street LJ; MacLeod AM; Pike A; Wood S; Thomas S; Brown TA; Smith A; Pillai G; Almond S; Guscott MR; Burns HD; Eng W; Ryan C; Cook J; Hamill TG
    ACS Med Chem Lett; 2010 Oct; 1(7):350-4. PubMed ID: 24900218
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery of an Orally Bioavailable Gonadotropin-Releasing Hormone Receptor Antagonist.
    Kim SM; Lee M; Lee SY; Park E; Lee SM; Kim EJ; Han MY; Yoo T; Ann J; Yoon S; Lee J; Lee J
    J Med Chem; 2016 Oct; 59(19):9150-9172. PubMed ID: 27608177
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
    Gale JD; Berger B; Gilbert S; Popa S; Sultan MB; Schachar RA; Girgenti D; Perros-Huguet C
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2659-2669. PubMed ID: 29847672
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists.
    Cai C; Kang FA; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z
    Bioorg Med Chem Lett; 2013 Jan; 23(1):351-4. PubMed ID: 23182090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.
    Meyers MJ; Arhancet GB; Hockerman SL; Chen X; Long SA; Mahoney MW; Rico JR; Garland DJ; Blinn JR; Collins JT; Yang S; Huang HC; McGee KF; Wendling JM; Dietz JD; Payne MA; Homer BL; Heron MI; Reitz DB; Hu X
    J Med Chem; 2010 Aug; 53(16):5979-6002. PubMed ID: 20672822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
    Munchhof MJ; Li Q; Shavnya A; Borzillo GV; Boyden TL; Jones CS; LaGreca SD; Martinez-Alsina L; Patel N; Pelletier K; Reiter LA; Robbins MD; Tkalcevic GT
    ACS Med Chem Lett; 2012 Feb; 3(2):106-11. PubMed ID: 24900436
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.
    Dorr P; Westby M; Dobbs S; Griffin P; Irvine B; Macartney M; Mori J; Rickett G; Smith-Burchnell C; Napier C; Webster R; Armour D; Price D; Stammen B; Wood A; Perros M
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4721-32. PubMed ID: 16251317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.